Literature DB >> 14692886

Investigation of cytokine (tumor necrosis factor-alpha, interleukin-6, interleukin-10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus.

K Baraczka1, K Nékám, T Pozsonyi, I Szüts, G Ormos.   

Abstract

Humoral immune response seems to play a role in the pathogenesis of multiple sclerosis (MS) and in the central nervous system (CNS) complications of systemic lupus erythematosus (SLE). The aim of the present study was to compare the levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and IL-10 in the cerebrospinal fluid of female patients with several forms of MS (50 patients), and in female patients with several types of CNS complications in SLE (50 patients). Samples were investigated using an enzyme-linked immunosorbent assay technique. Involvement of CNS in SLE patients seems to be characterized with elevated concentrations of all three cytokines in CNS and intrathecal synthesis of IL-6. In MS patients, an intrathecal synthesis of TNF-alpha (relapsing-remitting form) and IL-6 (primary progressive form) were observed. Clinical forms of MS seem to be immunologically heterogeneous. The activation of cytokine network was observed in SLE patients with CNS complications, independent of the pathological process. Similarities between SLE and MS patients with the primary progressive form of the disease were demonstrated concerning the intrathecal synthesis of IL-6. Only MS patients with the relapsing-remitting clinical form showed intrathecal TNF-alpha synthesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14692886     DOI: 10.1046/j.1351-5101.2003.00706.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  15 in total

1.  Purkinje neuron physiology is altered by the inflammatory factor interleukin-6.

Authors:  Donna L Gruol; Thomas E Nelson
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

Review 2.  Neuropsychiatric lupus: new mechanistic insights and future treatment directions.

Authors:  Noa Schwartz; Ariel D Stock; Chaim Putterman
Journal:  Nat Rev Rheumatol       Date:  2019-03       Impact factor: 20.543

3.  Neurological manifestations of connective tissue diseases mimicking multiple sclerosis.

Authors:  Sigliti-Henrietta Pelidou; Sotiris Giannopoulos; Sotiria Tzavidi; Niki Tsifetaki; Georgios Kitsos; Dimitrios Stefanou; Vassiliki Kostadima; Alexandros A Drosos; Athanassios P Kyritsis
Journal:  Rheumatol Int       Date:  2007-06-15       Impact factor: 2.631

Review 4.  Cytokine networks in systemic lupus erythematosus.

Authors:  Hooi-Ming Lee; Hidehiko Sugino; Norihiro Nishimoto
Journal:  J Biomed Biotechnol       Date:  2010-04-15

Review 5.  Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.

Authors:  Tony N Marion; Arnold E Postlethwaite
Journal:  Semin Immunopathol       Date:  2014-08-08       Impact factor: 9.623

6.  Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.

Authors:  Jing Wen; Yumin Xia; Ariel Stock; Jennifer S Michaelson; Linda C Burkly; Maria Gulinello; Chaim Putterman
Journal:  J Autoimmun       Date:  2013-04-08       Impact factor: 7.094

7.  Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain.

Authors:  Carrie L Tatar; Sunita Appikatla; Denise A Bessert; Ajaib S Paintlia; Inderjit Singh; Robert P Skoff
Journal:  ASN Neuro       Date:  2010-09-27       Impact factor: 4.146

Review 8.  Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.

Authors:  Michele L Pucak; Katherine A L Carroll; Douglas A Kerr; Adam I Kaplin
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

Review 9.  The Role of B Cells in Primary Progressive Multiple Sclerosis.

Authors:  Jameson P Holloman; Robert C Axtell; Nancy L Monson; Gregory F Wu
Journal:  Front Neurol       Date:  2021-06-07       Impact factor: 4.086

10.  Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.

Authors:  Takuya Matsushita; Takahisa Tateishi; Noriko Isobe; Tomomi Yonekawa; Ryo Yamasaki; Dai Matsuse; Hiroyuki Murai; Jun-Ichi Kira
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.